195 related articles for article (PubMed ID: 34533812)
1. C1q/tumor necrosis factor-related protein-3 acts as a target treating hepatic fibrosis.
Sun BR; Li HY; Wang GP; Jia QA; Zhang C
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5374-5382. PubMed ID: 34533812
[TBL] [Abstract][Full Text] [Related]
2. CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway.
Cheng C; Yu S; Kong R; Yuan Q; Ma Y; Yang W; Cao G; Xie L
Biomed Pharmacother; 2017 May; 89():1387-1391. PubMed ID: 28320106
[TBL] [Abstract][Full Text] [Related]
3. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
4.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
5. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
7. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis.
Yang Y; Sun M; Li W; Liu C; Jiang Z; Gu P; Li J; Wang W; You R; Ba Q; Li X; Wang H
Clin Transl Med; 2021 Jul; 11(7):e410. PubMed ID: 34323416
[TBL] [Abstract][Full Text] [Related]
8. Mediator subunit MED1 deficiency prevents carbon tetrachloride-induced hepatic fibrosis in mice.
Gao J; Bao M; Xing Y; Ding Y; Han T; Wen E; Liu J; Yue S; Wang R; Wang L; Liu J; Zhao S; Huang J; Liu E; Bai L
Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G418-G428. PubMed ID: 37668531
[TBL] [Abstract][Full Text] [Related]
9. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
10. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
[TBL] [Abstract][Full Text] [Related]
11. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
13. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
[TBL] [Abstract][Full Text] [Related]
14. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling.
Li J; Wang Y; Ma M; Jiang S; Zhang X; Zhang Y; Yang X; Xu C; Tian G; Li Q; Wang Y; Zhu L; Nie H; Feng M; Xia Q; Gu J; Xu Q; Zhang Z
EBioMedicine; 2019 Feb; 40():43-55. PubMed ID: 30639416
[TBL] [Abstract][Full Text] [Related]
15. miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis.
Roy S; Benz F; Vargas Cardenas D; Vucur M; Gautheron J; Schneider A; Hellerbrand C; Pottier N; Alder J; Tacke F; Trautwein C; Roderburg C; Luedde T
J Dig Dis; 2015 Sep; 16(9):513-24. PubMed ID: 26120970
[TBL] [Abstract][Full Text] [Related]
16. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling.
Song Y; Wei J; Li R; Fu R; Han P; Wang H; Zhang G; Li S; Chen S; Liu Z; Zhao Y; Zhu C; Zhu J; Zhang S; Pei H; Cheng J; Wu J; Dong L; Song G; Shen X; Yao Q
Hepatology; 2023 Nov; 78(5):1433-1447. PubMed ID: 36800849
[TBL] [Abstract][Full Text] [Related]
18. Targeting myosin 1c inhibits murine hepatic fibrogenesis.
Arif E; Wang C; Swiderska-Syn MK; Solanki AK; Rahman B; Manka PP; Coombes JD; Canbay A; Papa S; Nihalani D; Aspichueta P; Lipschutz JH; Syn WK
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1044-G1053. PubMed ID: 33908271
[TBL] [Abstract][Full Text] [Related]
19. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.
Pan XY; You HM; Wang L; Bi YH; Yang Y; Meng HW; Meng XM; Ma TT; Huang C; Li J
Theranostics; 2019; 9(15):4308-4323. PubMed ID: 31285763
[No Abstract] [Full Text] [Related]
20. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH
Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
